Cell Growth & Differentiation, Vol 5, Issue 12 1309-1319, Copyright © 1994 by American Association of Cancer Research

ARTICLES

Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation

J Taipale, S Matikainen, M Hurme and J Keski-Oja
Department of Virology, University of Helsinki, Finland.

The human myeloid leukemia cell lines HL-60, U-937, and THP-1 were used to analyze the alterations of transforming growth factor beta (TGF-beta) during hematopoietic cell growth and differentiation. Differentiation of these cell lines was induced by the phorbol ester phorbol 12-myristate 13-acetate, tumor necrosis factor alpha or by retinoic acid. Northern hybridization analyses indicated that the basal levels of TGF-beta 1, latent TGF-beta binding protein, and type II TGF-beta receptor (T beta IIR) mRNAs were low in untreated cells. Major increases of these mRNAs were observed in cells treated with phorbol 12-myristate 13-acetate, with maximal induction after 12-72 h of stimulation. Retinoic acid and tumor necrosis factor alpha elevated significantly only the expression of T beta IIR mRNA. TGF-beta 1 induced its receptor mRNA in HL-60 and U937-1SF cells but not in THP-1 cells. These changes in gene expression were related to the differentiation of myeloid leukemia cells. Affinity labeling with 125I-TGF-beta 1 indicated that type I TGF-beta receptor was coregulated with T beta IIR. Types I and II receptors were coprecipitated by T beta IIR-specific antibodies. Differentiation of myeloid cells induced secretion of latent TGF-beta 1 protein, as shown by immunoblotting, but significant changes in the levels of active TGF-beta were not observed. These results indicate that the genes involved in TGF-beta signal transduction are coordinately up-regulated during myeloid differentiation.

This article has been cited by other articles:

				J. P. Annes, Y. Chen, J. S. Munger, and D. B. Rifkin Integrin {alpha}V{beta}6-mediated activation of latent TGF-{beta} requires the latent TGF-{beta} binding protein-1 J. Cell Biol., June 7, 2004; 165(5): 723 - 734. [Abstract] [Full Text] [PDF]

				R. E. Brown and N. R. Kamal The Reed-Sternberg Cell: Molecular Characterization by Proteomic Analysis with Therapeutic Implications Ann. Clin. Lab. Sci., October 1, 2002; 32(4): 339 - 351. [Abstract] [Full Text] [PDF]

				J. R. Biggs and A. S. Kraft The Role of the Smad3 Protein in Phorbol Ester-induced Promoter Expression J. Biol. Chem., December 24, 1999; 274(52): 36987 - 36994. [Abstract] [Full Text] [PDF]

				R. Baier, T. Bondeva, R. Klinger, A. Bondev, and R. Wetzker Retinoic Acid Induces Selective Expression of Phosphoinositide 3-Kinase {{gamma}} in Myelomonocytic U937 Cells Cell Growth Differ., June 1, 1999; 10(6): 447 - 456. [Abstract] [Full Text]

				J. W. Maciaszek, S. J. Coniglio, D. A. Talmage, and G. A. Viglianti Retinoid-Induced Repression of Human Immunodeficiency Virus Type 1 Core Promoter Activity Inhibits Virus Replication J. Virol., July 1, 1998; 72(7): 5862 - 5869. [Abstract] [Full Text] [PDF]

				D. H. Kim, J. H. Chang, K. H. Lee, H.-Y. Lee, and S.-J. Kim Mechanism of E1A-Induced Transforming Growth Factor-beta (TGF-beta ) Resistance in Mouse Keratinocytes Involves Repression of TGF-beta Type II Receptor Transcription J. Biol. Chem., January 3, 1997; 272(1): 688 - 694. [Abstract] [Full Text] [PDF]